Baseline characteristics in the study cohort by treatment period (pre-ERAS and post-ERAS)
| Baseline characteristics | Pre-ERAS (n=243) | Post-ERAS (n=196) | P value | |
| Age, median (IQR‡), years | 63.5 (52.9-71.3) | 64.7 (54.5-72.3) | 0.25 | |
| Weight, median (IQR‡), years | 68.0 (60.8-78.0) | 74.0 (64.0-82.0) | 0.006 | |
| Cohort 1, ‘advanced’ (n=235) | 118 (49%) | 117 (60%) | 0.021 | |
| Cohort 2, ‘suspicious pelvic tumor’ (n=204) | 125 (51%) | 79 (40%) | ||
| ASA score* (n=435) | I | 23 (10%) | 6 (3%) | 0.041 |
| II | 166 (69%) | 146 (75%) | ||
| II | 49 (20%) | 38 (20%) | ||
| IV | 3 (1%) | 4 (2%) | ||
| Age adjusted Charlson Comorbidity Index (n=439) | <6 | 229 (94%) | 187 (95%) | 0.97 |
| ≥6 | 14 (6%) | 9 (5%) | ||
| Surgical complexity score† (n=439) | Low | 138 (57%) | 113 (58%) | 0.88 |
| Intermediate | 84 (34%) | 64 (32%) | ||
| High | 21 (9%) | 19 (10%) | ||
| Pre-operative anemia, g/dL (n=439) | <12 | 69 (28%) | 59 (30%) | 0.75 |
| Pre-operative albumin, g/L (n=434) | <35 | 20 (8%) | 10 (5%) | 0.25 |
| ≥35 | 219 (90%) | 185 (94%) | ||
*ASA score: American Society of Anesthesiologists physical status classification system.
†Aletti surgical complexity score.19
‡IQR: Interquartile range
ERAS, enhanced recovery after surgery.